{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T18:43:14Z","timestamp":1770576194645,"version":"3.49.0"},"reference-count":37,"publisher":"Japan Neurosurgical Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2024,3,15]]},"DOI":"10.2176\/jns-nmc.2023-0200","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T22:11:37Z","timestamp":1706047897000},"page":"116-122","source":"Crossref","is-referenced-by-count":2,"title":["Characteristics of MicroRNA Expression Depending on the Presence or Absence of Meningioma in Patients with Neurofibromatosis Type 2: A Secondary Analysis"],"prefix":"10.2176","volume":"64","author":[{"given":"Takeshi","family":"IMURA","sequence":"first","affiliation":[{"name":"Department of Rehabilitation, Faculty of Health Sciences, Hiroshima Cosmopolitan University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"MITSUHARA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"HORIE","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","unstructured":"1) Evans DG, Huson SM, Donnai D, et al.: A clinical study of type 2 neurofibromatosis. Q J Med<\/i> 84: 603-618, 1992"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Evans DG: Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis<\/i> 4: 16, 2009","DOI":"10.1186\/1750-1172-4-16"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Goutagny S, Bah AB, Henin D, et al.: Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features. Neuro Oncol<\/i> 14: 1090-1096, 2012","DOI":"10.1093\/neuonc\/nos129"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Mantripragada KK, Buckley PG, Jarbo C, Menzel U, Dumanski JP: Development of NF2 gene specific, strictly sequence defined diagnostic microarray for deletion detection. J Mol Med (Berl)<\/i> 81: 443-451, 2003","DOI":"10.1007\/s00109-003-0458-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Bachir S, Shah S, Shapiro S, et al.: Neurofibromatosis type 2 (NF2) and the implications for vestibular schwannoma and meningioma pathogenesis. Int J Mol Sci<\/i> 22: 690, 2021","DOI":"10.3390\/ijms22020690"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Asthagiri AR, Parry DM, Butman JA, et al.: Neurofibromatosis type 2. Lancet<\/i> 373: 1974-1986, 2009","DOI":"10.1016\/S0140-6736(09)60259-2"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Baser ME, Friedman JM, Aeschliman D, et al.: Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet<\/i> 71: 715-723, 2002","DOI":"10.1086\/342716"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Evans DG, Baser ME, O'Reilly B, et al.: Management of the patient and family with neurofibromatosis 2: a consensus conference statement. Br J Neurosurg<\/i> 19: 5-12, 2005","DOI":"10.1080\/02688690500081206"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell<\/i> 136: 215-233, 2009","DOI":"10.1016\/j.cell.2009.01.002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Wang M, Zhang H, Yang F, et al.: miR-188-5p suppresses cellular proliferation and migration via IL6ST: a potential noninvasive diagnostic biomarker for breast cancer. J Cell Physiol<\/i> 235: 4890-4901, 2020","DOI":"10.1002\/jcp.29367"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Tang H, Ma M, Dai J, et al.: miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy. J Exp Clin Cancer Res<\/i> 38: 212, 2019","DOI":"10.1186\/s13046-019-1190-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Johnson JL: Elucidating the contributory role of microRNA to cardiovascular diseases (a review). Vascul Pharmacol<\/i> 114: 31-48, 2019","DOI":"10.1016\/j.vph.2018.10.010"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Xu W, Gao L, Zheng J, et al.: The roles of microRNAs in stroke: possible therapeutic targets. Cell Transplant<\/i> 27: 1778-1788, 2018","DOI":"10.1177\/0963689718773361"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Imura T: Exploratory integrated analysis of circulating exosomal miRNA and tissue mRNA related to long-term physical activity for more than 25 years: a bioinformatics study. Eur J Appl Physiol<\/i> 123: 1447-1454, 2023","DOI":"10.1007\/s00421-023-05165-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ghai V, Fallen S, Baxter D, et al.: Alterations in plasma microRNA and protein levels in war veterans with chronic mild traumatic brain injury. J Neurotrauma<\/i> 37: 1418-1430, 2020","DOI":"10.1089\/neu.2019.6826"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Imura T, Shimizu K, Mitsuhara T: Distinctive microRNA profiles in serum of patients with neurofibromatosis type 2: a bioinformatic exploratory study. World Neurosurg<\/i> 164: e127-e133, 2022","DOI":"10.1016\/j.wneu.2022.04.042"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Saydam O, Shen Y, W\u00fcrdinger T, et al.: Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt\/beta-catenin signaling pathway. Mol Cell Biol<\/i> 29: 5923-5940, 2009","DOI":"10.1128\/MCB.00332-09"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Khomtchouk BB, Hennessy JR, Wahlestedt C: shinyheatmap: ultra fast low memory heatmap web interface for big data genomics. PLOS ONE<\/i> 12: e0176334, 2017","DOI":"10.1371\/journal.pone.0176334"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ye S, Eisinger-Mathason TS: Targeting the Hippo pathway: clinical implications and therapeutics. Pharmacol Res<\/i> 103: 270-278, 2016","DOI":"10.1016\/j.phrs.2015.11.025"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Pobbati AV, Kumar R, Rubin BP, Hong W: Therapeutic targeting of TEAD transcription factors in cancer. Trends Biochem Sci<\/i> 48: 450-462, 2023","DOI":"10.1016\/j.tibs.2022.12.005"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Baia GS, Caballero OL, Orr BA, et al.: Yes-associated protein 1 is activated and functions as an oncogene in meningiomas. Mol Cancer Res<\/i> 10: 904-913, 2012","DOI":"10.1158\/1541-7786.MCR-12-0116"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Lee NH, Kim SJ, Hyun J: MicroRNAs regulating hippo-YAP signaling in liver cancer. Biomedicines<\/i> 9: 347, 2021","DOI":"10.3390\/biomedicines9040347"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Liu T, Nie F, Yang X, et al.: MicroRNA-590 is an EMT-suppressive microRNA involved in the TGF\u03b2 signaling pathway. Mol Med Rep<\/i> 12: 7403-7411, 2015","DOI":"10.3892\/mmr.2015.4374"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Pecina-Slaus N, Cicvara-Pecina T, Kafka A: Epithelial-to-mesenchymal transition: possible role in meningiomas. Front Biosci (Elite Ed)<\/i> 4: 889-896, 2012","DOI":"10.2741\/e427"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Tripathi SK, Mathaiyan J, Kayal S, Nachiappa Ganesh R: Identification of differentially expressed mirna by next generation sequencing in locally advanced breast cancer patients of south Indian origin. Asian Pac J Cancer Prev<\/i> 23: 2255-2261, 2022","DOI":"10.31557\/APJCP.2022.23.7.2255"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Song W, Tang L, Xu Y, et al.: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer. Sci Rep<\/i> 7: 42319, 2017","DOI":"10.1038\/srep42319"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Wang F, Dai M, Chen H, et al.: Prognostic value of hsa-mir-299 and hsa-mir-7706 in hepatocellular carcinoma. Oncol Lett<\/i> 16: 815-820, 2018","DOI":"10.3892\/ol.2018.8710"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Minezaki T, Usui Y, Asakage M, et al.: High-throughput microRNA profiling of vitreoretinal lymphoma: vitreous and serum microRNA profiles distinct from uveitis. J Clin Med<\/i> 9: 1844, 2020","DOI":"10.3390\/jcm9061844"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Janpipatkul K, Trachu N, Watcharenwong P, et al.: Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients. Cancer Biomark<\/i> 31: 281-294, 2021","DOI":"10.3233\/CBM-203075"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Rodrigues DVS, Monteiro VVS, Navegantes-Lima KC, et al.: MicroRNAs in cell cycle progression and proliferation: molecular mechanisms and pathways. Non-Coding RNA Investig<\/i> 2: 28, 2018","DOI":"10.21037\/ncri.2018.04.06"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Yang Z, Chen JS, Wen JK, et al.: Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel. J Exp Clin Cancer Res<\/i> 36: 178, 2017","DOI":"10.1186\/s13046-017-0649-3"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Zhou DD, Li HL, Liu W, et al.: miR-193a-3p promotes the invasion, migration, and mesenchymal transition in glioma through regulating BTRC. Biomed Res Int<\/i> 2021: 8928509, 2021","DOI":"10.1155\/2021\/8928509"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Gokhale A, Kunder R, Goel A, et al.: Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway. J Cancer Res Ther<\/i> 6: 521-529, 2010","DOI":"10.4103\/0973-1482.77072"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Bharambe HS, Joshi A, Yogi K, Kazi S, Shirsat NV: Restoration of miR-193a expression is tumor-suppressive in MYC amplified Group 3 medulloblastoma. Acta Neuropathol Commun<\/i> 8: 70, 2020","DOI":"10.1186\/s40478-020-00942-5"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Chen S, Deng X, Sheng H, et al.: Noncoding RNAs in pediatric brain tumors: molecular functions and pathological implications. Mol Ther Nucleic Acids<\/i> 26: 417-431, 2021","DOI":"10.1016\/j.omtn.2021.07.024"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Fu C, Marczyk M, Samuels M, et al.: Targeted RNAseq assay incorporating unique molecular identifiers for improved quantification of gene expression signatures and transcribed mutation fraction in fixed tumor samples. BMC Cancer<\/i> 21: 114, 2021","DOI":"10.1186\/s12885-021-07814-8"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Wright C, Rajpurohit A, Burke EE, et al.: Comprehensive assessment of multiple biases in small RNA sequencing reveals significant differences in the performance of widely used methods. BMC Genomics<\/i> 20: 513, 2019","DOI":"10.1186\/s12864-019-5870-3"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/64\/3\/64_2023-0200\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T04:33:55Z","timestamp":1710563635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/64\/3\/64_2023-0200\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2176\/jns-nmc.2023-0200","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]},"article-number":"2023-0200"}}